VJETNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as VTAK
Flyte Aviation, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.82−0.02 (-2.62%)
Close on Oct 19, 2026
- Market cap
- $2.26M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2016 to 2025
Gross margin
92.3%+830.9 pts over 5 years
Operating margin
-2581.6%+11086.8 pts over 5 years
Net margin
-2098.0%+11818.9 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +95.0% | +288.2% | +25.9% | – | |
| Gross profit | +100.0% | – | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -132.8% | -182.7% | |
| Return on assets | – | -93.0% | -78.8% | |
| Current ratio | – | 3.56 | 0.10 | |
| Debt to equity | – | 0.07 | – | |
| Net debt to EBITDA | – | 0.68× | – | |
| Interest coverage | – | -327.8× | – | |
| Inventory turnover | – | 1.2× | 1.1× | |
| Capex to revenue | – | 25.9% | 2.1% | |
| Diluted shares | – | 0M | 1M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Flyte Aviation generated $88.38M from operations and spent $442.00K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$88.38M
Used
$442.00K
Capital expenditure$442.00K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-2098.0%
×Asset turnover0.04×
×Equity multiplier2.32×
=Return on equity, FY2025-182.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -2098.0% | 0.04× | 2.32× | -182.7% |
| FY2024 | -3962.6% | 0.01× | 1.78× | -101.0% |
| FY2023 | -15966.5% | 0.02× | 1.56× | -463.5% |
| FY2022 | -191892.9% | 0.00× | 1.65× | -234.3% |
| FY2021 | -113954.5% | 0.00× | 1.56× | -144.0% |
| FY2020 | -13917.0% | 0.01× | 1.43× | -132.8% |
| FY2019 | -791.2% | 0.12× | 1.18× | -114.1% |
| FY2018 | -492.8% | 0.15× | 1.44× | -104.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$17.18M
- Cash generatingOperating cash flow above zero-$8.30M
- Return on assets improvedROA up on the prior year-54.1% → -61.9%
- Earnings backed by cashOperating cash flow above net income-$8.30M vs -$17.18M
- Less leverageLong-term debt to assets fell5.4% → –
- Better liquidityCurrent ratio rose1.48 → 0.10
- No dilutionShare count did not rise0M → 1M
- Gross margin improvedGross margin up on the prior year90.00% → 92.31%
- More efficientAsset turnover rose0.01 → 0.03